Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2015 16:30 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Report First Quarter 2015 Financial Results on Thursday, May 7, 2015

SOUTH SAN FRANCISCO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
April 22, 2015 09:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Announces Clinical Data Presentation at ASCO 2015

SOUTH SAN FRANCISCO, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
April 21, 2015 07:45 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Highlights Results From Six Preclinical Abstracts at the American Association for Cancer Research Annual Meeting 2015

-Potential Biomarker Response to CB-839 Among KRAS and EGFR Mutant Cell Lines -Synergy of CB-839 with Signal Transduction Pathways SOUTH SAN FRANCISCO, Calif., April 21, 2015 (GLOBE NEWSWIRE) --...
April 09, 2015 09:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Present at the 14th Annual Needham Healthcare Conference

SOUTH SAN FRANCISCO, Calif., April 9, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 26, 2015 16:05 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Reports Fourth Quarter and Full Year 2014 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., March 26, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 20, 2015 08:30 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Report Fourth Quarter and Year-End 2014 Financial Results on Thursday, March 26, 2015

SOUTH SAN FRANCISCO, Calif., March 20, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 18, 2015 16:29 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Announces Five Data Presentations at the American Association for Cancer Research Annual Meeting 2015

SOUTH SAN FRANCISCO, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA) a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 05, 2015 16:02 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Gains Exclusive, Worldwide License to TransTech Pharma's Hexokinase II Inhibitor Program

SOUTH SAN FRANCISCO, Calif., March 5, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
February 03, 2015 09:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Present at the BIO CEO & Investor and Leerink Global Healthcare Conferences in February

SOUTH SAN FRANCISCO, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
January 30, 2015 09:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Appoints Keith Orford, M.D., Ph.D. to Vice President of Clinical Development

SOUTH SAN FRANCISCO, Calif., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...